MICHELLE LOPEZ: Open Payments
NPI 1821577552 · HARLINGEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,125 in 56 payments from 8 companies in 2025. Trend: 2023 $450 · 2024 $720 · 2025 $1,125
Food & beverage: $1,125
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 7 | $226 |
| Janssen Biotech, Inc. | 5 | $217 |
| ABBVIE INC. | 16 | $165 |
| Ipsen Biopharmaceuticals, Inc | 11 | $162 |
| Phathom Pharmaceuticals, Inc. | 3 | $160 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $153 |
| Lilly USA, LLC | 1 | $25 |
| Novo Nordisk Inc | 1 | $16 |
Products named: IBSRELA, TREMFYA, VOQUEZNA, XIFAXAN, IQIRVO, CREON, LINZESS, MAVYRET.
Industry payments across TX — which companies pay providers there.
